About LifeSprout
LifeSprout is a company based in Baltimore (United States) founded in 2015 by Justin Sacks, Sashank Reddy, Russell Martin, Mohamed Benjelloun, and Hai-Quan Mao.. LifeSprout has raised $44.7 million across 5 funding rounds from investors including Maryland.gov, Medytox and TEDCO. The company has 12 employees as of December 31, 2022. LifeSprout offers products and services including Tissue Restoration Platform and Regenerative Medicine Suite. LifeSprout operates in a competitive market with competitors including Augmenix, AmacaThera, Regentis Biomaterials, Carbylan and Biosyntech, among others.
- Headquarter Baltimore, United States
- Employees 12 as on 31 Dec, 2022
- Founders Justin Sacks, Sashank Reddy, Russell Martin, Mohamed Benjelloun, Hai-Quan Mao
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lifesprout, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$44.7 M (USD)
in 5 rounds
-
Latest Funding Round
$28.5 M (USD), Series A
Apr 21, 2020
-
Investors
Maryland.gov
& 9 more
-
Employee Count
12
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LifeSprout
LifeSprout offers a comprehensive portfolio of products and services, including Tissue Restoration Platform and Regenerative Medicine Suite. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Products that mimic body tissues for soft tissue restoration purposes
Suite of products for enhancing form and function in patients
Unlock access to complete
Funding Insights of LifeSprout
LifeSprout has successfully raised a total of $44.7M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $28.5 million completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $28.5M
-
First Round
First Round
(21 Feb 2018)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2020 | Amount | Series A - LifeSprout | Valuation | Redmile Group | |
| May, 2019 | Amount | Series A - LifeSprout | Valuation | Kairos Ventures , TEDCO |
|
| Jun, 2018 | Amount | Series A - LifeSprout | Valuation | Kairos Ventures , Triskelion Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in LifeSprout
LifeSprout has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Maryland.gov, Medytox and TEDCO. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital investments are provided by Emerald.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life sciences, physical sciences, and technology companies
|
Founded Year | Domain | Location | |
|
Venture capital fund and startup accelerator programs focused on seed and early stage companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by LifeSprout
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - LifeSprout
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lifesprout Comparisons
Competitors of LifeSprout
LifeSprout operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Augmenix, AmacaThera, Regentis Biomaterials, Carbylan and Biosyntech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Hydrogel spacers are provided for prostate cancer radiation therapy.
|
|
| domain | founded_year | HQ Location |
Injectable hydrogel platform developed for therapeutic medical applications.
|
|
| domain | founded_year | HQ Location |
Regentis Biomaterials is focused on tissue repair hydrogel technology.
|
|
| domain | founded_year | HQ Location |
Hyaluronic acid polymers are developed into therapeutics for pain management.
|
|
| domain | founded_year | HQ Location |
Biotherapeutic thermogels are developed for tissue repair applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lifesprout
Frequently Asked Questions about LifeSprout
When was LifeSprout founded?
LifeSprout was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Where is LifeSprout located?
LifeSprout is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
Who is the current CEO of LifeSprout?
Sashank Reddy is the current CEO of LifeSprout. They have also founded this company.
Is LifeSprout a funded company?
LifeSprout is a funded company, having raised a total of $44.7M across 5 funding rounds to date. The company's 1st funding round was a Series A of $6.5M, raised on Feb 21, 2018.
How many employees does LifeSprout have?
As of Dec 31, 2022, the latest employee count at LifeSprout is 12.
What does LifeSprout do?
LifeSprout was founded in 2015 in Baltimore, United States, within the biotechnology sector focused on tissue engineering. An injectable hydrogel product called Scaffold, composed of biodegradable nanofibers, is offered for applications in cancer reconstruction, trauma repair, and cosmetics. The material occupies space to support tissue growth, permits cell permeability, and dissolves in body fluids. It enables breast reconstruction for mastectomy patients without harvesting tissue from other areas.
Who are the top competitors of LifeSprout?
LifeSprout's top competitors include AmacaThera, Augmenix and Regentis Biomaterials.
What products or services does LifeSprout offer?
LifeSprout offers Tissue Restoration Platform and Regenerative Medicine Suite.
Who are LifeSprout's investors?
LifeSprout has 10 investors. Key investors include Maryland.gov, Medytox, TEDCO, Redmile Group, and unknown.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.